ATE190486T1 - Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen - Google Patents

Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen

Info

Publication number
ATE190486T1
ATE190486T1 AT97927037T AT97927037T ATE190486T1 AT E190486 T1 ATE190486 T1 AT E190486T1 AT 97927037 T AT97927037 T AT 97927037T AT 97927037 T AT97927037 T AT 97927037T AT E190486 T1 ATE190486 T1 AT E190486T1
Authority
AT
Austria
Prior art keywords
buckminsterfullerene
neurotoxic injury
treat
treat neurotoxic
injury
Prior art date
Application number
AT97927037T
Other languages
English (en)
Inventor
Dennis Wonkyu Choi
Laura Dugan
Tien-Sung Tom Linn
Tien-Yah Luh
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE190486T1 publication Critical patent/ATE190486T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97927037T 1996-06-03 1997-05-26 Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen ATE190486T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1889996P 1996-06-03 1996-06-03
PCT/EP1997/002679 WO1997046227A1 (en) 1996-06-03 1997-05-26 The use of buckminsterfullerene for treatment of neurotoxic injury

Publications (1)

Publication Number Publication Date
ATE190486T1 true ATE190486T1 (de) 2000-04-15

Family

ID=21790333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97927037T ATE190486T1 (de) 1996-06-03 1997-05-26 Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen

Country Status (16)

Country Link
EP (1) EP0904070B1 (de)
JP (1) JP2000514412A (de)
KR (1) KR20000016238A (de)
CN (1) CN1221340A (de)
AR (1) AR007369A1 (de)
AT (1) ATE190486T1 (de)
AU (1) AU720528B2 (de)
BR (1) BR9709636A (de)
CA (1) CA2255913C (de)
DE (1) DE69701458T2 (de)
DK (1) DK0904070T3 (de)
ES (1) ES2145608T3 (de)
GR (1) GR3033646T3 (de)
PT (1) PT904070E (de)
TR (1) TR199802504T2 (de)
WO (1) WO1997046227A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538153B1 (en) 2001-09-25 2003-03-25 C Sixty Inc. Method of synthesis of water soluble fullerene polyacids using a macrocyclic malonate reactant
US20030162837A1 (en) * 2002-02-23 2003-08-28 Dugan Laura L. Carboxyfullerenes and methods of use thereof
US7145032B2 (en) * 2002-02-23 2006-12-05 Washington University Therapeutic malonic acid/acetic acid C60 tri-adducts of buckminsterfullerene and methods related thereto
ATE431737T1 (de) * 2003-03-10 2009-06-15 Mitsubishi Corp Antihepatitis-c-virus-mittel und anti-hiv-mittel
EP1615609A2 (de) * 2003-04-10 2006-01-18 C Sixty, Inc. Fulleren-zusammensetzungen zur linderung von dermatologischen erkrankungen
US7163956B2 (en) * 2003-10-10 2007-01-16 C Sixty Inc. Substituted fullerene compositions and their use as antioxidants
WO2006028635A2 (en) * 2004-09-02 2006-03-16 C Sixty Inc. Fullerene compositions for ameliorating hearing loss, collateral damage of chemotherapy, or mucositis
JP6471288B2 (ja) * 2014-12-19 2019-02-20 昭和電工株式会社 フラーレン組成物、樹脂添加剤および樹脂組成物
TWI704127B (zh) * 2017-03-16 2020-09-11 國立臺灣大學 富勒烯衍生物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5864796A (en) * 1995-05-19 1996-11-29 Sphere Biosystems, Inc. Multiply-substituted fullerenes and methods for their prepar ation and characterization

Also Published As

Publication number Publication date
ES2145608T3 (es) 2000-07-01
DE69701458T2 (de) 2000-09-07
DK0904070T3 (da) 2000-06-26
BR9709636A (pt) 1999-08-10
PT904070E (pt) 2000-08-31
KR20000016238A (ko) 2000-03-25
AU720528B2 (en) 2000-06-01
EP0904070A1 (de) 1999-03-31
DE69701458D1 (de) 2000-04-20
AU3167297A (en) 1998-01-05
CA2255913A1 (en) 1997-12-11
TR199802504T2 (xx) 1999-03-22
GR3033646T3 (en) 2000-10-31
CN1221340A (zh) 1999-06-30
CA2255913C (en) 2007-07-31
AR007369A1 (es) 1999-10-27
JP2000514412A (ja) 2000-10-31
WO1997046227A1 (en) 1997-12-11
EP0904070B1 (de) 2000-03-15

Similar Documents

Publication Publication Date Title
ATE365042T1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE69724016D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
DE69736230D1 (de) Behandlung einer hämoglobinstörung
DE69720463T2 (de) Sulfonamid-derivate und ihre verwendung zur behandlung von zns-erkrankungen
DE69941566D1 (de) N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
ATA46794A (de) Einrichtung zur behandlung von hautzonen
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69634951D1 (de) Topische verwendung von betulinsäure zur behandlung bösartiger melanome
ATE218355T1 (de) Verwendung von mycobacterium zur tumorbehandlung
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE60015516D1 (de) Verwendung von makroliden zur behandlung von trockenen augen
DE69702862D1 (de) Verwendung von sulfatierten polysacchariden zur behandlung einer chronischer verletzung
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
ATE190486T1 (de) Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen
DE69716896D1 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
ATE270102T1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69621447D1 (de) Verwendung von nitroflavonoide zur behandlung von angstzuständen
ATE209891T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69518438D1 (de) Behandlung von übereregten nervenzellenfunktionen
DE59808165D1 (de) Verwendung von aminothiazolen zur wund- und hautbehandlung
ATE204167T1 (de) Antikonvulsive derivate zur behandlung von psoriasis
ATE216885T1 (de) Verwendung von penciclovir zur behandlung von postherpetischer neuralgie
DE69726054D1 (de) Zellen zur behandlung von demenz

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee